Insulin Resistance
Insulin Resistance is a metabolic condition involving reduced insulin sensitivity. It is discussed in relation to blood glucose, glycosylated haemoglobin, weight loss, and beta-cell function.
Insulin Resistance is classified as a metabolic condition, providing a focused starting point for learning about this health topic.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
What may help
What studies found for each option, best evidence first.
4 options:1 some evidence2 not enough evidence1 not tested in people
FastingpracticeSome evidence it helpsSize of effect: Not known
Some human studies found a benefit. More research could change this.
All 2 studies with a clear result found a benefit.
Pooled analyses whose designs were not recorded reported HOMA-IR reductions of −0.6 with intermittent fasting and −0.7 with combined IHT+IF. In a randomized trial of 68 people, HOMA-IR also decreased versus control, with stronger effects in a post hoc lower-HGH subgroup.
Open the Fasting pageStrength TrainingpracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
Pooled analyses whose designs were not recorded, based on a single study that included older participants, reported that UP reduced insulin resistance more than LP in men.
Open the Strength Training pageHigh-Intensity Interval Training (HIIT)practiceNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
In a trial of 90 participants, HIIT reduced HOMA-IR compared with control.
Open the High-Intensity Interval Training (HIIT) pageCardiopracticeNot tested in people
Only tested in animals, cells or theory. Results like these often do not carry over to people.
The one study found a benefit.
Open the Cardio page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this condition4 listedMost likely to help, from the evidence we have
- →PracticesFastingCertaintyMediumSourceRCT
Pooled analyses whose designs were not recorded reported HOMA-IR reductions of −0.6 with intermittent fasting and −0.7 with combined IHT+IF. In a randomized trial of 68 people, HOMA-IR also decreased versus control, with stronger effects in a post hoc lower-HGH subgroup.
Who was studied
- People with a condition
- Hypercholesterolemia
- Metabolic Syndrome
Open FastingStudy result
Pooled HOMA-IR reductions (IF only −0.6; combined IHT+IF −0.7); authors state IF shows particular promise for insulin-resistant patients by improving glucose homeostasis.
Low probability(3)
- →PracticesStrength TrainingCertaintyLowSourceRCT
Pooled analyses whose designs were not recorded, based on a single study that included older participants, reported that UP reduced insulin resistance more than LP in men.
Who was studied
- People with a condition
Open Strength TrainingStudy result
UP more effective than LP in reducing insulin resistance in men, based on a single study including older participants
- →PracticesHigh-Intensity Interval Training (HIIT)CertaintyLowSourceClinical
In a trial of 90 participants, HIIT reduced HOMA-IR compared with control.
Who was studied
- People with a condition
Open High-Intensity Interval Training (HIIT)Study result
HOMA-IR was the primary outcome and was reduced by HIIT versus control.
- →PracticesCardioCertaintyLowSourceTheoretical
Regular aerobic training improves insulin sensitivity in insulin-resistant adults.
What to avoid
Interventions recorded as making it worseNothing in this library is currently recorded as making Insulin Resistance worse. Coverage is partial, and absence here is not evidence of safety.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Insulin Resistance is a metabolic condition involving reduced insulin sensitivity. It is discussed in relation to blood glucose, glycosylated haemoglobin, weight loss, and beta-cell function. Its relevance may differ depending on whether an insulin-sensitivity defect predominates or beta-cell failure has occurred. Research summaries include options such as Alpha-Lipoic Acid (ALA) and Ashwagandha, but these examples do not establish that every person will benefit.
Evidence-backed options
The options associated with insulin resistance do not represent one uniform approach. Findings come from reviews, clinical studies, randomized controlled trials, and animal research, and the populations studied are not consistently specified. Some evidence concerns people with obesity or insulin resistance, while other findings come from obese mice or rats, so results from animal research may not directly apply to people.
Human findings include reports involving Ashwagandha, Beetroot Extract, Cranberry Extract, Milk Thistle (Silymarin), and Psyllium Husk. The Psyllium Husk finding included lifestyle modification, while the Milk Thistle (Silymarin) result involved non-diabetic women with obesity and insulin resistance. These details matter because the observed effects may depend on the accompanying intervention and the characteristics of the people studied.
The findings are not uniformly positive. Omega-3 showed no overall effect on estimates of insulin sensitivity, and Resveratrol 150 mg/d for 6 mo had no beneficial effect on insulin sensitivity when assessed by the Matsuda index. GABA and MCT Oil are supported here by animal research, whereas several other options rely mainly on reviews or limited clinical findings. The available information does not establish how quickly effects appeared, how long most options were taken, or whether benefits extend across all forms and stages of insulin resistance. Any medical condition warrants discussion with a clinician.